Risk of hip/femur fractures in patients using antipsychotics.

[1]  R. Murray,et al.  Effects of long-term prolactin-raising antipsychotic medication on bone mineral density in patients with schizophrenia , 2004, British Journal of Psychiatry.

[2]  Abraham Weizman,et al.  Risperidone, but not olanzapine, decreases bone mineral density in female premenopausal schizophrenia patients. , 2003, The Journal of clinical psychiatry.

[3]  Liam Smeeth,et al.  Exposure to tricyclic and selective serotonin reuptake inhibitor antidepressants and the risk of hip fracture. , 2003, American journal of epidemiology.

[4]  Corri Black,et al.  Validity of the General Practice Research Database , 2003, Pharmacotherapy.

[5]  D. Goff,et al.  Hyperprolactinemia and bone mineral density: the potential impact of antipsychotic agents , 2003, Psychoneuroendocrinology.

[6]  A. Wieck,et al.  Antipsychotic-induced hyperprolactinaemia in women: pathophysiology, severity and consequences , 2003, British Journal of Psychiatry.

[7]  C. Cooper,et al.  Utility of medical and drug history in fracture risk prediction among men and women. , 2002, Bone.

[8]  J. Avorn,et al.  Zolpidem Use and Hip Fractures in Older People , 2001, Journal of the American Geriatrics Society.

[9]  J. Avorn,et al.  Hazardous benzodiazepine regimens in the elderly: effects of half-life, dosage, and duration on risk of hip fracture. , 2001, The American journal of psychiatry.

[10]  L Abenhaim,et al.  The use of a large pharmacoepidemiological database to study exposure to oral corticosteroids and risk of fractures: validation of study population and results , 2000, Pharmacoepidemiology and drug safety.

[11]  G. Clifford,et al.  Medical Therapy for Benign Prostatic Hyperplasia: A Review of the Literature , 2000, European Urology.

[12]  A. Klibanski,et al.  Amenorrheic Bone Loss , 1999 .

[13]  R. Petty.  Prolactin and antipsychotic medications: mechanism of action , 1999, Schizophrenia Research.

[14]  F. Kummer,et al.  Do all hip fractures result from a fall? , 1999, American journal of orthopedics.

[15]  M. Tinetti,et al.  Drugs and Falls in Older People: A Systematic Review and Meta‐analysis: I. Psychotropic Drugs , 1999, Journal of the American Geriatrics Society.

[16]  A. Veld.  Symptomatic BPH and Hypertention: Does Comorbidity Affect Quality of Life? , 1998 .

[17]  T. Walley,et al.  The UK General Practice Research Database , 1997, The Lancet.

[18]  J. Lieberman,et al.  Mechanisms of action of atypical antipsychotic drugs: a critical analysis , 1996, Psychopharmacology.

[19]  F Sturmans,et al.  Benzodiazepines and the risk of falling leading to femur fractures. Dosage more important than elimination half-life. , 1995, Archives of internal medicine.

[20]  N. Rojansky,et al.  Decreased Bone Mineral Density in Medicated Psychiatric Patients , 1995, Psychosomatic medicine.

[21]  E. Seeman,et al.  The bone density of female twins discordant for tobacco use. , 1994, The New England journal of medicine.

[22]  A Haines,et al.  Accuracy of diagnosis of psychosis on general practice computer system. , 1993, BMJ.

[23]  R. Klineberg,et al.  Psychotropics, thiazide diuretics and hip fractures in the elderly , 1993, The Medical journal of Australia.

[24]  J. Rodés,et al.  Reduced spinal and femoral bone mass and deranged bone mineral metabolism in chronic alcoholics. , 1992, Alcohol and alcoholism.

[25]  W A Ray,et al.  Benzodiazepines of long and short elimination half-life and the risk of hip fracture. , 1989, JAMA.

[26]  A. Klibanski,et al.  Importance of gonadal steroids to bone mass in men with hyperprolactinemic hypogonadism. , 1989, Annals of internal medicine.

[27]  O. Johnell,et al.  Drug consumption in patients with hip fractures compared with controls. , 1987, Comprehensive gerontology. Section A, Clinical and laboratory sciences.

[28]  L. Melton,et al.  Psychotropic drug use and the risk of hip fracture. , 1987, The New England journal of medicine.

[29]  B. Sherman,et al.  Bone density in amenorrheic women with and without hyperprolactinemia. , 1983, The Journal of clinical endocrinology and metabolism.

[30]  Di Chen,et al.  Growth Regulatory Factors and Bone , 2004, Reviews in Endocrine and Metabolic Disorders.

[31]  R. Cumming,et al.  Benzodiazepines and Risk of Hip Fractures in Older People , 2003, CNS drugs.

[32]  A. Klibanski,et al.  Clinical review 106: Amenorrheic bone loss. , 1999, The Journal of clinical endocrinology and metabolism.

[33]  J. Peedicayil,et al.  A study on serum prolactin levels in schizophrenia: correlation with positive and negative symptoms , 1993, International clinical psychopharmacology.

[34]  R. Gibbons,et al.  The efficacy of psychotropic drugs: implications for power analysis. , 1992, Psychopharmacology bulletin.

[35]  C. Christiansen,et al.  Calcium metabolism in schizophrenic patients on long-term neuroleptic therapy. , 1980, Neuropsychobiology.